Navigation Links
BioMed Realty Trust Reports Second Quarter 2011 Financial Results
Date:8/3/2011

0,000 square feet of future redevelopment and development potential. Concurrently, the company announced the signing of a new 15-year lease with Acorda Therapeutics, Inc. for approximately 138,200 square feet of laboratory and office space. Pursuant to the lease agreement, BioMed will proceed on an extensive renovation of the property over the next twelve months, bringing the estimated total investment in the property upon lease commencement to approximately $36.0 million.
  • 1701 / 1711 Research Boulevard in Rockville, Maryland, for $17.5 million consisting of a single building comprising approximately 104,700 square feet of laboratory and office space and approximately 145,000 square feet of development potential.
  • 450 Kendall Street in Cambridge, Massachusetts comprising approximately 33,500 square feet of development potential in the Kendall Square area for $5.0 million.

  • At June 30, 2011, the company's total portfolio comprised 12.3 million square feet, with an additional 3.5 million square feet of development potential. The current operating portfolio's leased percentage was approximately 90.5% leased at quarter end.

    Subsequent to quarter end, the company completed the early delivery of its Gazelle Court property, a 176,000 square foot build-to-suit research facility for Isis Pharmaceuticals, Inc. in Carlsbad, California, with Isis leasing the new building for a 20-year term.

    The company's property portfolio included the following as of June 30, 2011:Rentable Square FeetCurrent operating

    9,395,591Long-term lease up

    1,389,517Redevelopment

    357,817Development

    176,000Unconsolidated partnership portfolio

    954,558Total property portfolio

    12,273,483Development potential

    3,506,937Total portfolio

    15,780,420Financing ActivitySubsequent to the quarter end, the company entered into a new $750 million unsecured revolving credit facility, replacing the previous unsecured revolving cr
    '/>"/>

    SOURCE BioMed Realty Trust, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related medicine technology :

    1. Boston University Biomedical Engineers Find Chink in Bacterias Armor
    2. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
    3. Saladax Biomedicals 5-FU Personalized Chemotherapy Management (PCM(R)) Assay CE Marked for Distribution in the EU
    4. Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications
    5. The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards
    6. NIH Funds New Wellstone Research Center for Muscular Dystrophy at Boston Biomedical Research Institute
    7. OmegaGenesis Unveils Novel Nanotechnology Platform With Broad Biomedical Applications
    8. Oramed Pharmaceuticals to Present at the 8th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2009
    9. Subsidiary of Nova Biomedical Completes Acquisition of Assets of CCS Medicals Subsidiary, Sanvita, Inc.
    10. Voler Systems President Speaks at BIOMEDevice San Jose
    11. Nominations Open for the 2010 Dr. Paul Janssen Award for Biomedical Research
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/19/2014)... , Aug. 19, 2014 Research and ... Products - Global Strategic Business Report" report to their ... for Anti-Adhesion Products in US$ Thousands by the following three ... Procedures. The report provides separate comprehensive analytics for ... , Europe , Asia-Pacific ...
    (Date:8/18/2014)... and HERZLIYA-PITUACH, Israel , Aug. ... OMX First North Premier, Stockholm : "IMNP"), ... that its application to list its common stock on the ... Market, a unit of the NASDAQ OMX Group. IMMUNE,s common ... Market at the opening of trading on August 21, 2014 ...
    (Date:8/18/2014)... 2014 Reportlinker.com announces that a new market ... Russia Sinuscopes Market Outlook to 2020 ... Market Outlook to 2020 Summary ... 2020", provides key market data on the Russia Sinuscopes ... dollars, volume (in units) and average prices (in US ...
    Breaking Medicine Technology:Global Anti-Adhesion Products - Strategic Business Report 2014 2Immune Pharmaceuticals Announces Approval for Listing on the NASDAQ Capital Market 2Immune Pharmaceuticals Announces Approval for Listing on the NASDAQ Capital Market 3Immune Pharmaceuticals Announces Approval for Listing on the NASDAQ Capital Market 4Russia Sinuscopes Market Outlook to 2020 2Russia Sinuscopes Market Outlook to 2020 3Russia Sinuscopes Market Outlook to 2020 4
    ... , SCOTTSDALE, Ariz. , Jan. 22 Matrixx Initiatives, ... financial results for the fiscal 2010 third quarter, ended December 31, ... January 25, 2010 . An earnings conference call will be held the ... AM ET . , To access the teleconference, please call (888) 452-4006 ...
    ... ... Called Ampyra, to Improve Walking for People With All Types of ... The U.S. Food and Drug Administration has approved the ... Therapeutics) for its ability to improve walking speed in people with ...
    Cached Medicine Technology:Matrixx Initiatives, Inc. Sets Time for Discussion of Third Quarter Fiscal 2010 Financial Results 2Ampyra is First Symptom Management Drug Developed Specifically to Treat MS, the First Oral MS Therapy Approved for MS, and the First New FDA Approved Therapy to Come Through the MS Pipeline Since 2004 2Ampyra is First Symptom Management Drug Developed Specifically to Treat MS, the First Oral MS Therapy Approved for MS, and the First New FDA Approved Therapy to Come Through the MS Pipeline Since 2004 3Ampyra is First Symptom Management Drug Developed Specifically to Treat MS, the First Oral MS Therapy Approved for MS, and the First New FDA Approved Therapy to Come Through the MS Pipeline Since 2004 4Ampyra is First Symptom Management Drug Developed Specifically to Treat MS, the First Oral MS Therapy Approved for MS, and the First New FDA Approved Therapy to Come Through the MS Pipeline Since 2004 5Ampyra is First Symptom Management Drug Developed Specifically to Treat MS, the First Oral MS Therapy Approved for MS, and the First New FDA Approved Therapy to Come Through the MS Pipeline Since 2004 6
    (Date:8/19/2014)... editorial published in this week,s JAMA highlights ... tools when considering how to treat patients. Written by ... Center and chair of pediatrics at Boston University School ... JAMA , the editorial examines results of a study ... an example of how doctors can often over-emphasize certain ...
    (Date:8/19/2014)... Kars4Kids , a national nonprofit organization ... partnership with New York State Senator Gustavo Rivera to ... The giveaway will take place in conjunction with Rivera’s ... August 22. , “With a mission focused on ... children for school with the necessary supplies is imperative,” ...
    (Date:8/19/2014)... August 19, 2014 “ Inbox Blueprint ... course designed to provide users with the tools necessary ... marketing techniques and strategies. The course which was ... of excitement throughout the internet marketing world. The commotion ... HonestyFirstReviews.com's Tiffany Hendricks prompting an updated review of the ...
    (Date:8/19/2014)... (HealthDay News) -- Lupus and other rheumatic diseases ... seizures, which can delay a correct diagnosis for ... rheumatic diseases can also cause these types of ... Center in Maywood, Ill. Rheumatic disorders include ... soft tissues, such as lupus, systemic vasculitis and ...
    (Date:8/19/2014)... 2014 In honor of National Dog Day on ... old furry friend by offering tips on caring for aging dogs. ... more. Because of this, dog owners need to realize the dog’s ... age, their needs change. They will not want to spend as ... used to. Because of this, pet owners should consider altering the ...
    Breaking Medicine News(10 mins):Health News:Review of clinical treatment of bronchiolitis in infants reveals over-reliance on one test 2Health News:Backpack Giveaway Kars4Kids Partners with New York State Senator Gustavo Rivera to Prepare Bronx Students for New School Year 2Health News:Anik Singal’s “Inbox Blueprint” Review Released By HonestyFirstReviews.com 2Health News:Certain Symptoms Can Delay Lupus Diagnosis, Researchers Report 2Health News:The Puppy Store Helps Pet Owners Care for Aging Dogs 2
    ... Oct. 4 The following is a,statement regarding Microsoft,s ... information online:, It is encouraging that companies like ... health record (PHR) products and systems,that people can use ... companies will follow suit. Having ready access to your ...
    ... Orr, fired for managing diabetes at work but ... Thursday before House Judiciary,Subcommittee about his experience, ... today reiterated its strong support for the ADA,Restoration ... the landmark,1990 Americans with Disabilities Act. On Thursday, ...
    ... ACTON, Mass., Oct. 4 Psychemedics Corporation,(AMEX: ... joined the company,as Vice President, Controller. Jennifer ... financial,reporting activities, as well as the financial analysis ... Jennifer will,report directly to the Chairman and CEO. ...
    ... Connector, provides patients with virtual diabetes health- ... management ... Association today unveiled a new web-based diabetes tool that,makes it ... -- to,share and organize important health information to improve their ...
    ... BOSTON, Oct. 4 Diet.com has joined ... of the newly launched Microsoft,HealthVault consumer health ... which currently include,Diet.com Calorie/Meal Tracker, Diet.com Weight ... incorporated into HealthVault. The trackers will,enable users ...
    ... Oct. 4 Genta,Incorporated (Nasdaq: GNTA ) announced ... Raymond P. Warrell, Jr., will provide an,update of corporate ... 10th at 2:15 pm PDT. The conference will be ... The presentation will be webcast and accessible at the ...
    Cached Medicine News:Health News:Statement Regarding Microsoft's Announcement of New Services to Help People Store Their Health Information Online 2Health News:American Diabetes Association Urges Congress to Pass ADA Restoration Act, Help End Employment Discrimination Against Americans with Diabetes 2Health News:American Diabetes Association Urges Congress to Pass ADA Restoration Act, Help End Employment Discrimination Against Americans with Diabetes 3Health News:Jennifer Chmieleski Joins Psychemedics Corporation as Top Financial Officer 2Health News:New Diabetes Tool Available on American Diabetes Association Web Site 2Health News:New Diabetes Tool Available on American Diabetes Association Web Site 3Health News:New Diabetes Tool Available on American Diabetes Association Web Site 4Health News:Diet.com Enters Strategic Collaboration To Support Microsoft HealthVault 2Health News:Genta to Present at Bio Investor Forum 2007 Conference 2Health News:Genta to Present at Bio Investor Forum 2007 Conference 3
    ... doubled Nd:YAG laser is mounted on Haag ... selected between 0.2 and 2.0 mJ. The ... and 700 microns. Knobs for laser energy ... on the laser head. The laser system ...
    ... Tango ophthalmic laser system provides two lasers ... and a photodisruptor for posterior capsulotomy and ... Nd:YAG producing pulsed 532 nm light. The ... nm. The appropriate laser can be easily ...
    ... Glaucoma Laser System features a patented technique ... glaucoma. It selectively targets pigmented cells and ... Selecta II is equipped with a Q-switch ... light, which induces the same cell replacement ...
    Thin and smooth jaws, designed to enter trough 3 mm incision, cross action....
    Medicine Products: